Caltalks' interview with our CEO
BMG Pharma: leadership in the Oral Care and Aesthetic Medicine sector
The double soul of BMG Pharma and our future challenges
Caltalks' interview with our CEO
The latest news
The double soul of BMG Pharma and our future challenges
A great success for BMG Pharma News!
Since 2011, BMG Pharma has been an Italian excellence serving the biotechnology sector, which is bringing great innovations to the biopolymers sector.
Follow the Sole24Ore interview with our CEO Marco Mastrodonato regarding the new Hyaluromimethic ® technological platform and the projects in development.
BMG Pharma
We Make it Happen
A business plan focused on commercial expansion, research and development. In two years, the company created 4 new patents and registered 36 innovative products, as well as launching 37 on an international scenario.
Massimo Doris, CEO of Banca Mediolanum buys 2% of the share package, creating a corporate form with the company specializing in the production of new biomaterials derived from hyaluronic acid.